Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality June 14, 2004
Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography June 1, 2004
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebocontrolled dose-effect study November 13, 2003
Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics July 1, 2003
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism June 14, 2003
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. March 1, 2003
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia February 1, 2003
